New stem cell trial offers hope for sickle cell and thalassemia patients
NCT ID NCT06872333
First seen Mar 17, 2026 · Last updated May 21, 2026 · Updated 9 times
Summary
This study tests a stem cell transplant from a healthy donor for people with serious blood disorders like sickle cell disease or thalassemia. The goal is to replace the faulty blood cells with healthy ones, reducing the need for lifelong transfusions. Participants will receive a donor transplant and be monitored for side effects like graft-versus-host disease. The trial is currently recruiting 62 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOGLOBINOPATHIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Masonic Cancer Center
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact
Conditions
Explore the condition pages connected to this study.